MetLife Inc (MET) stock
METNYSELife InsuranceFiscal year ends December 31Also trades as MET.PA, MET.PE, MET.PF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3039% above fair value
$102.65+0.78 (+0.77%)
Close on Nov 13, 2026Market cap $65.23BP/E 13.4Yield 2.19%
MetLife EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
MetLife's EPS for the twelve months ending Sep 30, 2026 was $7.67, up 44.4% year over year. For fiscal 2025 it was $4.71, down 20.7% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is $7.65 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.71 | -20.7% |
| FY2024 | Dec 31, 2024 | $5.94 | +228.2% |
| FY2023 | Dec 31, 2023 | $1.81 | -71.3% |
| FY2022 | Dec 31, 2022 | $6.30 | -17.6% |
| FY2021 | Dec 31, 2021 | $7.65 | +34.7% |
| FY2020 | Dec 31, 2020 | $5.68 | -6.3% |
| FY2019 | Dec 31, 2019 | $6.06 | +23.4% |
| FY2018 | Dec 31, 2018 | $4.91 | +35.6% |
| FY2017 | Dec 31, 2017 | $3.62 | +440.3% |
| FY2016 | Dec 31, 2016 | $0.67 | -85.5% |
| FY2015 | Dec 31, 2015 | $4.62 | -14.8% |
| FY2014 | Dec 31, 2014 | $5.42 | +86.3% |
| FY2013 | Dec 31, 2013 | $2.91 | +159.8% |
| FY2012 | Dec 31, 2012 | $1.12 | -80.6% |
| FY2011 | Dec 31, 2011 | $5.76 | +101.4% |
| FY2010 | Dec 31, 2010 | $2.86 | – |
| FY2009 | Dec 31, 2009 | -$2.89 | -169.8% |
| FY2008 | Dec 31, 2008 | $4.14 | -24.5% |
| FY2007 | Dec 31, 2007 | $5.48 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.67 | +200.8% |
| Q2 FY2026 | Jun 30, 2026 | $1.09 | +5.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.74 | +35.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.17 | -34.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.22 | -32.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.03 | -19.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.28 | +16.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.78 | +131.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.81 | +223.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.28 | +166.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.10 | +5400.0% |
| Q4 FY2023 | Dec 31, 2023 | $0.77 | -60.7% |
| Q3 FY2023 | Sep 30, 2023 | $0.56 | -59.1% |
| Q2 FY2023 | Jun 30, 2023 | $0.48 | -55.6% |
| Q1 FY2023 | Mar 31, 2023 | $0.02 | -98.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.96 | +12.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.37 | -22.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.08 | -71.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.89 | +472.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.75 | +1150.0% |
| Q3 FY2021 | Sep 30, 2021 | $1.77 | +156.5% |
| Q2 FY2021 | Jun 30, 2021 | $3.83 | +5371.4% |
| Q1 FY2021 | Mar 31, 2021 | $0.33 | -93.1% |
| Q4 FY2020 | Dec 31, 2020 | $0.14 | -75.9% |
| Q3 FY2020 | Sep 30, 2020 | $0.69 | -70.0% |
| Q2 FY2020 | Jun 30, 2020 | $0.07 | -96.0% |
| Q1 FY2020 | Mar 31, 2020 | $4.75 | +239.3% |
| Q4 FY2019 | Dec 31, 2019 | $0.58 | -71.6% |
| Q3 FY2019 | Sep 30, 2019 | $2.30 | +161.4% |
| Q2 FY2019 | Jun 30, 2019 | $1.77 | +113.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.40 | +17.6% |
| Q4 FY2018 | Dec 31, 2018 | $2.04 | -4.7% |
| Q3 FY2018 | Sep 30, 2018 | $0.88 | – |
| Q2 FY2018 | Jun 30, 2018 | $0.83 | +3.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.19 | +50.6% |
| Q4 FY2017 | Dec 31, 2017 | $2.14 | – |
| Q3 FY2017 | Sep 30, 2017 | -$0.09 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.80 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.79 | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.17 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?